Choose a health supplement manufacturer only after verifying the exact production site, its legal role, product-specific cGMP evidence, written specifications, testing, dosage-form fit, total project economics, and postmarket responsibilities. Treat FDA registration as a basic status check, not proof that the FDA has approved the facility or product.
This guide gives brand founders, ecommerce operators, importers, and sourcing teams nine practical checks within a seven-step process.
What a capable manufacturer should actually provide
A qualified manufacturer should provide controlled production plus evidence that the promised product can be made consistently. The service may include custom formulation, ingredient sourcing, manufacturing, packaging, label support, testing, storage, or fulfillment, but the scope must be explicit.
Terms describe business models, not quality. A supplement contract manufacturer produces to an agreed specification. Private label or white label supplements often start with a supplier's formula. OEM commonly means production to buyer requirements, while ODM may add supplier-led design. Turnkey manufacturing can combine services, but it does not remove the brand owner's duties.
The nine-check qualification gate
Before investing in samples, apply these nine pass or fail checks. Pause before scoring vague answers.
| Check | Verify | Red flag |
|---|---|---|
| 1 | One defined product and commercial brief | Assumptions remain unwritten |
| 2 | Legal entity, exact site, and subcontractors | Supplier will not name the sites |
| 3 | U.S. registration and import roles where applicable | “FDA-approved” sales language |
| 4 | Product-specific cGMP evidence | Logos without scoped records |
| 5 | Exact dosage-form and scale-up capability | No relevant commercial-batch evidence |
| 6 | Sample, specifications, testing, stability, and label align | Sample is detached from production records |
| 7 | Product MOQ, packaging MOQ, and landed cost | Unit quote hides exclusions |
| 8 | Formula ownership and change control | Changes can occur without prior approval |
| 9 | Complaints, adverse events, traceability, and recalls | No named owners or response times |
Start with a complete product and commercial brief
Start with a written brief that makes supplier quotes comparable. Without one, each nutraceutical manufacturer may price a different product, test plan, pack format, or service scope.
Define formula status, ingredients, serving, dosage form, sensory requirements, allergen constraints, pack count, sales market, forecast volume, launch window, and target landed cost. State whether you want stock private label, an adjusted formula, or fully custom formulation, and identify who will own the technical file.
Send every candidate the same brief and require written assumptions. Honglan's overview of OEM and ODM supplement manufacturing helps frame build-to-specification production and supplier-assisted development.
Check 1: Can the manufacturer quote the same defined product and scope you intend to buy?
Confirm the site, legal role, and market pathway
Verify who does what, where, and under which market obligations before assessing sales claims. Request the legal name, physical address, applicable food facility registration details, and every subcontracted site or laboratory. Map formulation, manufacturing, packing, labeling, testing, holding, and export to named parties, then compare those names with contracts, COAs, invoices, and shipping documents.
For U.S. sales, the FDA's dietary supplement Q&A says facilities that manufacture, process, pack, or hold covered supplements must register where required. It also states that FDA does not approve dietary supplements or most labeling before marketing. The FDA separately explains that facility registration does not denote approval. Use “FDA-registered” only when verified, never “FDA-approved” or “FDA-certified.”
If importing, identify the importer of record and FSVP importer before signing. The FDA's FSVP key requirements factsheet says importers of finished dietary supplements may need most standard FSVP requirements, with verification focused on supplement cGMP compliance, subject to the applicable pathway and exemptions. Honglan's analysis of FDA compliance risks for U.S. supplements adds commercial context, but confirm obligations with qualified regulatory counsel.
Checks 2 and 3: Is the exact production site verified, and is every domestic or import role assigned?
Review product-specific cGMP controls and records
Audit the evidence chain for your product rather than accepting logos as a substitute for due diligence. FDA identifies 21 CFR Part 111 as the dietary supplement cGMP framework.
The FDA's Part 111 Small Entity Compliance Guide connects quality to identity, purity, strength, composition, contaminant limits, and conditions that prevent adulteration. It also assigns quality control review and approval duties for specifications, procedures, tests, supplier qualification, and relevant deviations.
Ask for a controlled, appropriately redacted evidence package:
| Request | What it helps you verify |
|---|---|
| Quality manual scope and organization chart | Quality control independence and site coverage |
| Product specifications and test methods | Acceptance criteria for ingredients, in-process material, and finished product |
| Sample master manufacturing record | Formula, process steps, controls, packaging, and label instructions |
| Anonymized batch production record | Whether actual production follows the approved master record |
| Representative Certificate of Analysis (COA) and laboratory details | Which tests are reported, by whom, and against which limits |
| Supplier qualification procedure | How ingredient and component suppliers are approved and monitored |
| Deviation and change-control procedures | How exceptions are investigated, approved, and documented |
| Traceability and recall procedure | Whether affected lots can be identified and acted on |
Confirm whether testing is in-house or performed by a qualified third-party laboratory, and how methods fit your product matrix. For each certificate, check the scope, site, standard, issuer, and expiry.
Check 4: Does the evidence show product-specific cGMP control from incoming components to released batch?
Match the dosage form to real production capability
Choose a manufacturer with demonstrated capability in your exact dosage form and process. A company that makes tablets well is not automatically the right partner for gummies, softgels, powders, liquid drops, pastes, or liquid drinks.
For formulation, ask about ingredient compatibility, serving size, sensory limits, processing losses, and scale-up criteria. For gummies, review texture, flavor, water activity, processing conditions, and packaging protection. Explore Honglan's gummy supplement formats only after confirming the formula can survive the process.
For hard capsules and softgels, examine fill properties, shell options, leakage or oxidation controls, and count accuracy. Compare Honglan's capsule manufacturing options with your stability needs. For powders, ask about flow, blend uniformity, flavor masking, fill, and moisture protection. Treat any supplier's product range as a format reference, not proof that a formula is production-ready.
Request examples relevant to the same dosage form and process, with confidential details removed. Then ask what changes between bench sample, pilot batch, and commercial scale.
Check 5: Can the site formulate, scale, manufacture, and package your specific product without outsourcing an undisclosed critical step?
Align samples, specifications, testing, and stability
Treat a sample as one part of a documented acceptance plan. Good taste, appearance, and texture do not prove commercial-scale identity, purity, strength, composition, contaminant control, or shelf life.
Set measurable sensory and physical criteria tied to the current formula revision, pack configuration, and signed sample. Before production, approve product and packaging specifications, label proof, test panel, methods, acceptance limits, and release authority.
Ask whether each lot receives a COA, which results are tested versus carried from supplier documents, and when an independent laboratory is used. Clarify reserve-sample retention, out-of-specification handling, and record access.
Stability testing should provide the basis for shelf life. Ask for the protocol, storage conditions, tested attributes, time points, packaging used, and rules for extending an initial expiry. Do not accept an unsupported shelf-life number copied from a similar formula.
Label review also needs defined ownership. The FDA states firms remain responsible for lawful labeling, while the FTC Health Products Compliance Guidance says advertising must be truthful and not misleading and objective claims require adequate substantiation. For a structure/function claim, maintain documented substantiation that supports the express and implied messages rather than relying on acceptable-sounding wording alone.
Check 6: Do the approved sample, specifications, test plan, COA, stability basis, and label version describe the same commercial product?
Calculate MOQ, lead time, packaging, and landed cost
Compare total landed project cost, not the unit quote. Product minimum order quantity and packaging MOQ can differ, leaving a brand with unused bottles, caps, labels, cartons, or film after the first production run.
Build one comparison sheet with these fields:
| Cost or timing field | Questions to resolve |
|---|---|
| Formula and development | Are samples, revisions, flavor work, and scale-up included? |
| Product MOQ | Is the minimum based on units, kilograms, batch size, or flavor? |
| Packaging MOQ | Which components exceed the product run, and who owns the remainder? |
| Testing and documentation | Which tests, COAs, label reviews, and export documents cost extra? |
| Lead time | When does the clock start, and what approvals or materials can stop it? |
| Logistics | Are freight, insurance, duties, customs, inspection, and local delivery included? |
| Inventory exposure | How much cash and shelf life remain tied up after launch? |
Calculate landed cost from manufacturing, development, testing, packaging, inspection, freight, insurance, duties, customs, warehousing, and unused-component exposure. Keep payment and currency assumptions visible.
Compare compatibility and minimums through the custom supplement packaging options. If timing is constrained, review the causes of slow supplement production. Brands testing demand can use the small-batch and low-MOQ guide to weigh lower opening inventory against higher per-unit cost.
Check 7: Does the commercial model show every minimum, dependency, exclusion, and landed-cost component?
Put ownership and postmarket duties in writing
Use a quality agreement and supply contract to assign decisions before a problem. A purchase order may not cover formulation ownership, change control, complaints, adverse events, recalls, and record access.
Your responsibility matrix should name an owner, approver, response time, and required record for each activity:
| Activity | Written decision required |
|---|---|
| Formula and intellectual property | Who owns the formula, methods, artwork, and technical file? |
| Supplier or process change | What requires prior notice or brand approval? |
| Batch release | Who reviews specifications, records, deviations, and COA results? |
| Label and claims | Who drafts, reviews, approves, and maintains substantiation? |
| Complaints | Who receives, investigates, trends, and closes each complaint? |
| Adverse events | Who triages, reports, follows up, and retains records? |
| Recall and traceability | Who decides, notifies, retrieves, reconciles, and pays? |
| Business continuity | What happens after a failed batch, shortage, or site interruption? |
For U.S. products, the manufacturer, packer, or distributor named on the label is generally the responsible person for serious adverse-event reporting, according to FDA adverse-event guidance. FDA says covered reports received through the label contact must be submitted within 15 business days. Contracts can address submission arrangements, but intake, forwarding, investigation, and recordkeeping need an operational workflow.
Checks 8 and 9: Are ownership and change control explicit, and can the parties execute complaint, adverse-event, traceability, and recall duties after sale?
Score qualified suppliers with a weighted comparison
Use a pass or fail compliance gate first, then score the suppliers that remain. Reject or pause any candidate that will not identify the site, provide relevant quality evidence, disclose critical subcontracting, or sign the responsibility matrix.
Rate each remaining category from 1 to 5, then multiply the rating by the weight and divide by 5. For example, a rating of 4 on the 30-point cGMP criterion earns 24 points.
| Criterion | Weight | What earns a high score |
|---|---|---|
| cGMP evidence and site transparency | 30% | Relevant, current, site-specific records with clear quality oversight |
| Dosage-form and formulation fit | 20% | Demonstrated process capability and credible scale-up plan |
| Specifications, testing, and stability | 15% | Coherent acceptance criteria, methods, COA, and shelf-life basis |
| Total project economics | 15% | Transparent MOQs, packaging exposure, landed cost, and payment terms |
| Execution and lead time | 10% | Named milestones, dependencies, owners, and escalation path |
| Postmarket accountability | 10% | Usable complaint, adverse-event, traceability, and recall workflow |
Record evidence beside every rating. A polished presentation should not outscore missing records, and a low quote should not compensate for a failed compliance gate.
Avoid these common sourcing mistakes
Costly mistakes can result when a supplier claim is treated as verified evidence.
- Calling registration approval: FDA registration is not FDA approval, certification, endorsement, or permission for a particular product claim.
- Auditing the company instead of the site: Confirm the facility that will perform each critical operation and any subcontracted laboratory or packer.
- Comparing unit price alone: Include testing, packaging surplus, freight, duties, storage, and cash tied up in inventory.
- Leaving changes informal: Require prior notice and approval rules for ingredients, suppliers, processes, specifications, test methods, packaging, and sites.
- Waiting until launch to assign postmarket work: Establish complaint intake, serious adverse-event escalation, traceability, and recall contacts before product release.
Frequently asked questions
Is a contract manufacturer different from a private label supplier?
Usually. Contract manufacturing may use a buyer-owned custom formula, while private label or white label supply often starts with a manufacturer-controlled stock formula. Ask who owns it, what can change, and whether other brands receive it.
What is a reasonable minimum order quantity for supplements?
There is no universal MOQ. It varies by dosage form, batch capacity, ingredients, flavor, testing, and packaging. Compare product and packaging MOQs separately, then calculate their inventory and cash exposure.
How long should supplement manufacturing take?
Lead time should be a dependency-based schedule, not a single promise. Formula approval, ingredients, packaging, testing, production scheduling, and freight can affect completion. Ask when the clock starts and what can reset it.
Is a domestic manufacturer always better than an overseas manufacturer?
No. Choose the supplier that meets your product, evidence, economics, and market-pathway requirements. Overseas sourcing adds import planning and may create FSVP duties. Domestic sourcing can simplify logistics, but location does not prove capability or compliance.
Apply the same evidence-based checklist to Honglan
Apply all nine checks to Honglan or any other health supplement manufacturer. Company-provided information says Guangdong Honglan Health Industry Co., Ltd. offers OEM, ODM, private label, and wholesale production across gummies, hard capsules, softgels, tablets, powders, liquid drops, pastes, and liquid drinks.
Company-provided information on Honglan's OEM/ODM page states that its facility covers 15,000 square meters with 15 automated production lines and lists cGMP, BRC, FSSC, HACCP, ISO 22000, and FDA registration. Request current, site-specific evidence for each statement and use “FDA-registered,” not “FDA-approved.”
The company's supplement manufacturing FAQ lists a 50-unit stock MOQ and generally 500 to 1,000 custom units. Because packaging, testing, destination, and transit affect schedules, request current project-specific dates and minimums in writing.
Contact Honglan for a documented project review and send a complete brief, evidence request list, and responsibility matrix with your inquiry.
